ES2061589T3 - Sistema de liberacion de principios activos implantable y biologicamente degradable. - Google Patents

Sistema de liberacion de principios activos implantable y biologicamente degradable.

Info

Publication number
ES2061589T3
ES2061589T3 ES88116522T ES88116522T ES2061589T3 ES 2061589 T3 ES2061589 T3 ES 2061589T3 ES 88116522 T ES88116522 T ES 88116522T ES 88116522 T ES88116522 T ES 88116522T ES 2061589 T3 ES2061589 T3 ES 2061589T3
Authority
ES
Spain
Prior art keywords
implantable
release system
active principles
biologically degradable
degradable active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88116522T
Other languages
English (en)
Inventor
Herbert Prof Dr Stricker
Gunther Dr Entenmann
Otto Dr Kern
Michel Dr Mikhail
Bernd Dr Zierenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim GmbH
Original Assignee
Boehringer Ingelheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim GmbH filed Critical Boehringer Ingelheim GmbH
Application granted granted Critical
Publication of ES2061589T3 publication Critical patent/ES2061589T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Prostheses (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PATENTE AFECTA A UN SISTEMA EXPENDEDOR DE SUSTANCIAS ACTIVAS IMPLANTABLE Y BIODEGRADABLE QUE CONSTA DE UN MATERIAL SOPORTE A BASE DE POLI-D,L-LACTIDA Y DE UNA SUSTANCIA ACTIVA INCORPORADA EN ESTE, ASI COMO, EN SU CASO, ADYUVANTES FARMACEUTICOS. EL MATERIAL SOPORTE CONTIENE CANTIDADES DEFINIDAS DE SUSTANCIAS ACCESORIAS EN FORMA DE FORMADORES DE POROS, HASTA UN 10% DEL PESO DE UN DISOLVENTE O UN ABLANDADOR FISIOLOGICAMENTE INOFENSIVO Y/O POLIMEROS DE BAJA MOLECULARIDAD.
ES88116522T 1987-10-09 1988-10-06 Sistema de liberacion de principios activos implantable y biologicamente degradable. Expired - Lifetime ES2061589T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873734223 DE3734223A1 (de) 1987-10-09 1987-10-09 Implantierbares, biologisch abbaubares wirkstofffreigabesystem

Publications (1)

Publication Number Publication Date
ES2061589T3 true ES2061589T3 (es) 1994-12-16

Family

ID=6338006

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88116522T Expired - Lifetime ES2061589T3 (es) 1987-10-09 1988-10-06 Sistema de liberacion de principios activos implantable y biologicamente degradable.

Country Status (17)

Country Link
EP (1) EP0311065B1 (es)
JP (1) JP2763303B2 (es)
KR (1) KR970006082B1 (es)
AT (1) ATE101035T1 (es)
AU (1) AU609194B2 (es)
CA (1) CA1333770C (es)
DE (2) DE3734223A1 (es)
DK (1) DK175252B1 (es)
ES (1) ES2061589T3 (es)
FI (1) FI100302B (es)
IE (1) IE62505B1 (es)
IL (1) IL87973A (es)
NO (1) NO176304C (es)
NZ (1) NZ226514A (es)
PH (1) PH30236A (es)
PT (1) PT88703B (es)
ZA (1) ZA887535B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5180765A (en) * 1988-08-08 1993-01-19 Biopak Technology, Ltd. Biodegradable packaging thermoplastics from lactides
US6323307B1 (en) 1988-08-08 2001-11-27 Cargill Dow Polymers, Llc Degradation control of environmentally degradable disposable materials
US5444113A (en) * 1988-08-08 1995-08-22 Ecopol, Llc End use applications of biodegradable polymers
US5252642A (en) * 1989-03-01 1993-10-12 Biopak Technology, Ltd. Degradable impact modified polyactic acid
US5216050A (en) * 1988-08-08 1993-06-01 Biopak Technology, Ltd. Blends of polyactic acid
US5424346A (en) * 1988-08-08 1995-06-13 Ecopol, Llc Biodegradable replacement of crystal polystyrene
US5702716A (en) * 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
ES2093647T3 (es) * 1989-06-05 1997-01-01 Massachusetts Inst Technology Polimeros bioerosionables para la liberacion de farmacos en los huesos.
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH679207A5 (es) * 1989-07-28 1992-01-15 Debiopharm Sa
JPH05503934A (ja) * 1990-01-30 1993-06-24 アクゾ・エヌ・ヴエー 壁により完全に包囲され、１種以上の活性物質で全部又は一部を充填した中空空間から成る、活性物質の調節送達のための物品
EP0447719B1 (en) * 1990-03-05 1993-11-03 Minnesota Mining And Manufacturing Company Device for extended delivery of pharmacologically active agents to the ear
US5350580A (en) * 1990-03-05 1994-09-27 Minnesota Mining And Manufacturing Company Device and method for extended delivery of pharmacologically active agents to the ear
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5605696A (en) * 1995-03-30 1997-02-25 Advanced Cardiovascular Systems, Inc. Drug loaded polymeric material and method of manufacture
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
WO1998045492A1 (en) * 1997-04-04 1998-10-15 Alcan International Limited Aluminum alloy composition and method of manufacture
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
US6261583B1 (en) 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
DE19908753C2 (de) * 1999-02-20 2003-10-02 Jenapharm Gmbh Bioabbaubare, injizierbare Oligomer-Polymer-Zusammensetzung
US6306425B1 (en) * 1999-04-09 2001-10-23 Southern Research Institute Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6702849B1 (en) 1999-12-13 2004-03-09 Advanced Cardiovascular Systems, Inc. Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
US6803443B1 (en) 2000-03-22 2004-10-12 Dainippon Ink And Chemicals, Inc. Impact modifier and polyester composition containing the modifier
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
EP1637126B1 (en) * 2000-07-05 2016-12-14 Allergan, Inc. Methods for treating inflammation of the eye
EP1339438B1 (en) 2000-11-29 2005-10-19 Allergan Inc. Preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
DE602005011928D1 (de) 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
US7771742B2 (en) 2004-04-30 2010-08-10 Allergan, Inc. Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
US8425929B2 (en) 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US9498457B2 (en) 2004-04-30 2016-11-22 Allergan, Inc. Hypotensive prostamide-containing biodegradable intraocular implants and related implants
US20050244458A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular neuropathies
US7993634B2 (en) 2004-04-30 2011-08-09 Allergan, Inc. Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US8722097B2 (en) 2004-04-30 2014-05-13 Allergan, Inc. Oil-in-water method for making polymeric implants containing a hypotensive lipid
US20050244463A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Sustained release intraocular implants and methods for treating ocular vasculopathies
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
WO2005107708A1 (en) 2004-04-30 2005-11-17 Allergan, Inc. Biodegradable intravitreal tyrosine kinase inhibitors implants
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
PT2010184E (pt) 2006-04-06 2013-04-03 Nupathe Inc Implantes para o tratamento dos estados associados à dopamina
US8802128B2 (en) 2006-06-23 2014-08-12 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8969415B2 (en) 2006-12-01 2015-03-03 Allergan, Inc. Intraocular drug delivery systems
US8956641B2 (en) * 2008-04-18 2015-02-17 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of inflammatory diseases
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
DK2498783T3 (en) 2009-11-09 2018-12-10 Allergan Inc COMPOSITIONS AND PROCEDURES FOR STIMULATING HAIR GROWTH
JP4779169B1 (ja) * 2010-10-27 2011-09-28 Ｎｅｃインフロンティア株式会社 ボタン照明構造、電子機器
EP2956096A1 (en) 2013-02-15 2015-12-23 Allergan, Inc. Sustained drug delivery implant
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
WO2019071245A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. IMPLANTABLE DEPOSITS FOR REGULATED RELEASE OF ANALGESICS TO TREAT POSTHOPERATIVE PAIN ASSOCIATED WITH ORTHOPEDIC SURGERY, AND RELATED DEVICES, SYSTEMS, AND METHODS
CN116650732A (zh) 2018-01-08 2023-08-29 铸造疗法股份有限公司 经由治疗剂的控制递送用于治疗腔内癌症的装置、系统和方法
US12458589B2 (en) 2018-05-12 2025-11-04 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
WO2020047013A1 (en) 2018-08-28 2020-03-05 Foundry Therapeutics, Inc. Polymer implants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL109293C (es) * 1955-12-22
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
DE3710175A1 (de) * 1987-02-12 1988-08-25 Hoechst Ag Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung

Also Published As

Publication number Publication date
CA1333770C (en) 1995-01-03
NO884474D0 (no) 1988-10-07
DK175252B1 (da) 2004-07-19
IE883040L (en) 1989-04-09
NO884474L (no) 1989-04-10
IL87973A0 (en) 1989-03-31
PT88703B (pt) 1992-12-31
JP2763303B2 (ja) 1998-06-11
IL87973A (en) 1992-08-18
PT88703A (pt) 1988-11-01
IE62505B1 (en) 1995-02-08
DE3734223A1 (de) 1989-04-20
DK561588A (da) 1989-04-10
KR970006082B1 (ko) 1997-04-23
NO176304B (no) 1994-12-05
KR890006222A (ko) 1989-06-12
PH30236A (en) 1997-02-05
NO176304C (no) 1995-03-22
AU2352288A (en) 1989-04-13
EP0311065A1 (de) 1989-04-12
ZA887535B (en) 1990-06-27
DE3887616D1 (de) 1994-03-17
JPH02117A (ja) 1990-01-05
FI884604L (fi) 1989-04-10
AU609194B2 (en) 1991-04-26
FI884604A0 (fi) 1988-10-07
ATE101035T1 (de) 1994-02-15
NZ226514A (en) 1990-02-26
DK561588D0 (da) 1988-10-07
EP0311065B1 (de) 1994-02-02
FI100302B (fi) 1997-11-14

Similar Documents

Publication Publication Date Title
ES2061589T3 (es) Sistema de liberacion de principios activos implantable y biologicamente degradable.
RU93004902A (ru) Композиция пролонгированного контролируемого высвобождения пептидного лекарственного вещества и способ ее получения
ES2113906T3 (es) Composiciones polimericas utiles como implantes con administracion controlada.
ES2149174T3 (es) Un sistema de vacunacion de una sola dosis.
CY1105051T1 (el) Παρασκευασμα σε μορφη υμενιου για τη διφασικη απελευθερωση ουσιων με φαρμακολογικη δραση ή αλλων ουσιων
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
ATE493114T1 (de) Mucoadhäsive zusammensetzung zur verabreichung von biologisch aktiven substanzen in tiergewebe
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
ES2104560T3 (es) Polipropileno modificado, procedimiento para fabricar un articulo a partir del mismo.
DE3850823D1 (de) System zur Freisetzung von Medikamenten und dessen Herstellungsmethode.
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
DE69101291D1 (de) Zusammensetzung zur kontrollierten Abgabe von Medikamenten.
DE69935605D1 (de) Ladung und abgabe von wasser unlöslicher arzneimittel
CY1105998T1 (el) Βελτιωμενη ενδοπροθετικη διαταξη
ES2116308T3 (es) Dispositivo implantable a base de un material polimero, que contiene principios activos farmaceuticos, asi como procedimiento para su produccion.
ES2159403T3 (es) Poliuretanos termoplasticos que contienen principios activos.
AR026621A1 (es) Sistemas terapeuticos transdermales con estabilidad mejorada y un procedimiento para su preparacion
ES2054403T3 (es) Procedimiento para la produccion de cuerpos de moldeo de dimensionado peque¦o con un elevado contenido en etofibrado y una liberacion controlada de la sustancia activa, su uso y formas de aplicacion de administracion oral derivadas de ello.
ES2158596T3 (es) Agentes para el tratamiento de las plantas.
AR012480A1 (es) Una unidad de dosis farmaceutica que comprende tibolona, un metodo para elaborarla y el uso de un producto de almidon como vehiculo en unidades dedosis farmaceuticas que comprenden tibolona
SE9603480D0 (sv) Beredningsform för svårlösliga läkemedel
DE68929117D1 (de) Chemische Verbindungen und pharmazeutische Zusammensetzungen zur Freisetzung von Arzneimitteln
GR1000266B (el) Μεθοδος παρασκευης μιας συνθεσης βασισμενης σε πολυεστερα για την ελεγχομενη εκλυση φαρμακευτικων ουσιων.
ES2096938T3 (es) Copolimeros alcoxilados y su utilizacion en la recurticion del cuero.
HU9203420D0 (en) Biologically decomposable polymers for medical preparatives of delayed releqse of active agents

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 311065

Country of ref document: ES